Showing results (91-100 of 110) with videos related to

Sort By:
Pageof 11
Analytical and Bioanalytical Chemistry|October 8, 2010
Simultaneous quantification of ten cytotoxic drugs by a validated LC-ESI-MS/MS methodSusanne Nussbaumer, Sandrine Fleury-Souverain, Paola Antinori, et al.
Pharmacogenomics|January 24, 2015
P-glycoprotein: a clue to vitamin K antagonist stabilizationLiliane Gschwind, Victoria Rollason, Françoise Boehlen, et al.
Plos Medicine|June 11, 2013
Patented drug extension strategies on healthcare spending: a cost-evaluation analysisNathalie Vernaz, Guy Haller, François Girardin, et al.
Swiss Medical Weekly|December 5, 2019
Immunosuppressant therapeutic drug monitoring and trough level stabilisation after paediatric liver or kidney transplantationKlara M Posfay-Barbe, Henri Baudet, Valérie A McLin, et al.
The Journal of Antimicrobial Chemotherapy|March 12, 2011
Modelling the impact of antibiotic use on antibiotic-resistant Escherichia coli using population-based data from a large hospital and its surrounding communityNathalie Vernaz, Benedikt Huttner, Daniel Muscionico, et al.
JPEN. Journal of Parenteral and Enteral Nutrition|December 7, 2019
E-Learning Training to Improve Pediatric Parenteral Nutrition Practice: A Pilot Study in Two University HospitalsLaetitia-Marie Petit, Pauline Le Pape, Stephanie Delestras, et al.
Pharmacogenomics|May 9, 2013
Impact of CYP2C9 polymorphisms on the vulnerability to pharmacokinetic drug-drug interactions during acenocoumarol treatmentLiliane Gschwind, Victoria Rollason, Françoise Boehlen, et al.
Plos One|July 16, 2019
Development of a predictive score for potentially avoidable hospital readmissions for general internal medicine patientsAnne-Laure Blanc, Thierry Fumeaux, Jérôme Stirnemann, et al.
BMC Medical Informatics and Decision Making|June 1, 2022
Development and assessment of PharmaCheck: an electronic screening tool for the prevention of twenty major adverse drug eventsChristian Skalafouris, Jean-Luc Reny, Jérôme Stirnemann, et al.
Pageof 11